EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Proteasome and Immunoproteasome Levels in Plasma and Peritoneal Fluid in Patients with Endometriosis

Monika Wróbel iD, Zielińska Zuzanna, Łukasz Ołdak iD, Aleksandra Kalicka iD, Grzegorz Mańka, Mariusz Kiecka, Robert Z Spaczyński iD, Piotr Piekarski, Beata Banaszewska, Artur Jakimiuk iD, Tadeusz Issat iD, Wojciech Rokita und 15 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241814363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Monika Wróbel und 26 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-015 Warsaw, Poland. Hauptthemen laut MEDLINE: Endometriosis, Proteasome Endopeptidase Complex, Ascitic Fluid, Biomarkers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Polish Ministry of Health, European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant, European Union’s Horizon 2020 Research and Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is a chronic disease in which the endometrium cells are located outside the uterine cavity. The aim of this study was to evaluate circulating 20S proteasome and 20S immunoproteasome levels in plasma and peritoneal fluid in women with and without endometriosis in order to assess their usefulness as biomarkers of disease. Concentrations were measured using surface plasmon resonance imaging biosensors. Patients with suspected endometriosis were included in the study—plasma was collected in 112 cases and peritoneal fluid in 75. Based on the presence of endometriosis lesions detected during laparoscopy, patients were divided into a study group (confirmed endometriosis) and a control group (patients without endometriosis). Proteasome and immunoproteasome levels in both the plasma (p = 0.174; p = 0.696, respectively) and the peritoneal fluid (p = 0.909; p = 0.284, respectively) did not differ between those groups. There was a statistically significant difference in the plasma proteasome levels between patients in the control group and those with mild (Stage I and II) endometriosis (p = 0.047) and in the plasma immunoproteasome levels in patients with ovarian cysts compared to those without (p = 0.017). The results of our study do not support the relevance of proteasome and immunoproteasome determination as biomarkers of the disease but suggest a potentially active role in the pathogenesis of endometriosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisProteasome Endopeptidase ComplexAscitic FluidBiomarkersHumansFemaleAdultMiddle AgedCase-Control Studies

Stichwörter der Autor:innen

endometriosisimmunoproteasomeperitoneal fluidplasmaproteasome

Substanzen

Proteasome Endopeptidase ComplexBiomarkers

Autor:innen und Institutionen

  • 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-015 Warsaw, Poland.
  • Bioanalysis Laboratory, Doctoral School of Exact and Natural Science, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.
  • Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.
  • Faculty of Medicine, Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland.
  • Angelius Provita Hospital, 40-611 Katowice, Poland.
  • Center for Gynecology, Obstetrics and Infertility Treatment Pastelova, 60-198 Poznan, Poland.

ORCID-Profile: Monika Wróbel, Łukasz Ołdak, Aleksandra Kalicka, Robert Z Spaczyński, Artur Jakimiuk, Tadeusz Issat, Jakub Młodawski, Grzegorz Raba, Cezary Wojtyła, Damian Warzecha, Mirosław Wielgoś

Förderung

  • Polish Ministry of Health
  • European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant
  • European Union’s Horizon 2020 Research and Innovation Program

Zitieren

APA

Wróbel, M., Zuzanna, Z., Ołdak, Ł., Kalicka, A., Mańka, G., Kiecka, M., Spaczyński, R. Z., Piekarski, P., Banaszewska, B., Jakimiuk, A., Issat, T., Rokita, W., Młodawski, J., Szubert, M., Sieroszewski, P., Raba, G., Szczupak, K., Kluz, T., Kluza, M., …, & Laudański, P. (2023). Evaluation of Proteasome and Immunoproteasome Levels in Plasma and Peritoneal Fluid in Patients with Endometriosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241814363

Vancouver

Wróbel M, Zuzanna Z, Ołdak Ł, Kalicka A, Mańka G, Kiecka M, et al. Evaluation of Proteasome and Immunoproteasome Levels in Plasma and Peritoneal Fluid in Patients with Endometriosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241814363

BibTeX
@article{Wrbel2023,
  author = {Wróbel, Monika and Zuzanna, Zielińska and Ołdak, Łukasz and Kalicka, Aleksandra and Mańka, Grzegorz and Kiecka, Mariusz and Spaczyński, Robert Z and Piekarski, Piotr and Banaszewska, Beata and Jakimiuk, Artur and Issat, Tadeusz and Rokita, Wojciech and Młodawski, Jakub and Szubert, Maria and Sieroszewski, Piotr and Raba, Grzegorz and Szczupak, Kamil and Kluz, Tomasz and Kluza, Marek and Pierzyński, Piotr and Wojtyła, Cezary and Lipa, Michał and Warzecha, Damian and Wielgoś, Mirosław and Sawicki, Włodzimierz and Gorodkiewicz, Ewa and Laudański, Piotr},
  title = {Evaluation of Proteasome and Immunoproteasome Levels in Plasma and Peritoneal Fluid in Patients with Endometriosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241814363}
}
Kostenlos starten →